Shares of CryoPort, Inc. (CYRX) have gained 7.3% over the past four weeks to close the last trading session at $6.03, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $10.94 indicates a potential upside of 81.4%.The mean estimate comprises nine short-term price targets with a standard deviation of $3.05. While the lowest estimate of $6.50 indicates a 7.8% increase from the curren ...

Shares of CryoPort, Inc. (CYRX) have gained 22.5% over the past four weeks to close the last trading session at $7.07, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $10.94 indicates a potential upside of 54.7%.The average comprises nine short-term price targets ranging from a low of $6.50 to a high of $15, with a standard deviation of $3.05. While the lowest estimate indicates ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313393 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identi ...

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.35%. A quarter ago, it was expected that this company would post a loss of $0.33 per share when it actually produced a loss of $0.42, delivering a surprise of -27.27%.Over the last four quarters, the company has surpassed ...

Cryoport (CYRX) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Todd Fromer - Managing Partner - Head of Investor RelationJerrell Shelton - President & CEOKyle Crews - Equity Research AssociateMark Sawicki - Chief Scientific OfficerNone - ExecutiveRobert Stefanovich - CFO & TreasurerDavid Larsen - Managing DirectorSubbu Nambi - Managing Director Conference Call Participants Richard Baldry - MD & Senior Research AnalystNone - AnalystMatthew Stanton - AnalystAnna Snopkowski - Equity Resear ...

Cryoport (CYRX) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Good afternoon, and welcome to Cryoport First Quarter twenty twenty five Earnings Call. All participants will start in a listen only mode. After the speakers' presentation, there will be a question and answer session and instructions will be provided at that time. As a reminder, this call is being recorded. I will now turn the call over to your host, Todd Frommer from KCSA Strategic Communications. Please go ahead, sir. Speaker1 Thank y ...

Exhibit 99.1 Cryoport Reports First Quarter 2025 Financial Results NASHVILLE, Tennessee, May 7, 2025, - Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global provider of temperature-controlled supply chain solutions for the life sciences sector, today announced financial results for the first quarter (Q1) ended March 31, 2025. Jerrell Shelton, CEO of Cryoport, commented, "We delivered a strong start to the year with $41.0 million of revenue from continuing operations, which represented 10% year-over-year growt ...

Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over year Q1 2025 revenue from continuing operations of $41.0 million, up 10% year over year Supporting 711 global clinical trials as of March 31, 2025 Strategic partnership with DHL; CRYOPDP divestiture expected to close Q2/Q3 2025NASHVILLE, Tenn., May 7, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global provider of temperature-controlled supply chain solutions for the life sciences sector, today announced financial ...

Cryoport, Inc. (NASDAQ:CYRX) Strategic Agreement and Transaction with DHL Group Call March 31, 2025 8:30 AM ET Company Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Tom Heinzen - Vice President, Corporate Development & Investor Relations Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Conference Call Participants Todd Fromer Thank you, operator. Before we begin today, I would like to remind everyone ...

Cryoport's Strategic Agreement and Transaction with DHL Group March 2025 © 2025 CRYOPORT, INC. 1 Forward Looking Statements Statements in this presentation which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans, or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, ...